A review of required monitoring and management of physical health parameters in patients being treated with clozapine
AimsTo review available standards for physical health monitoring in people taking clozapine To audit current practice against standards To identify changes in practice and facilitate a re-audit to assess impact of any changesMethodStandard: CG178 Psychosis and Schizophrenia in Adults: Prevention and Management – NICE, February 2014Target:100%Exceptions: NoneSample: The original audit included all 58 patients from the Worcester clozapine clinic, as per October 2018. The re-audit reviewed a random sample of all patients attending the clozapine clinics in Worcester, Kidderminster and Redditch, as part of Worcestershire Health and Care NHS Trust, as per October 2019. A total of 66 patients were selected.Data Source: Carenotes and ICEResultAreas of good practice:Monitoring of HbA1c and FBC remains goodThere has been an improvement in monitoring alcohol use, substance misuse and side effectsAreas requiring improvement:There continues to be limited recording of respiratory rateThere has been a decline in recording temperature, BMI and concomitant therapiesPotential reasoning for missing data includes:Staff not knowing the monitoring requirements, which is more likely to be an issue when staff members running the clinics change frequentlyMonitoring being completed but not documentedPatients’ refusal of monitoringData being recorded in alternative locations including general practice, without communication between servicesPatients moving between teams or having inpatient stays may disrupt monitoring regimeConclusionLIMITATIONSThis audit assumes all patients involved to be on a stable dose of clozapine with routine monitoringSome patients may have been transferred between teams or inpatients during the period of data collectionThere is no scope to record when patients refuse monitoringWe may not have access to all notes such as those from general practice for data collectionRECOMMENDATIONSInduction programme for junior doctors to include education on clozapine monitoringTraining for staff involved in clozapine clinics to ensure better understanding of monitoring requirementsProcurement of ECG machines for each site and relevant training for nursing and medical staffCollaboration with GPs for shared dataRe-audit in 1 year